BridgeBio Pharma (BBIO) Insider Trading & Ownership $23.42 +0.18 (+0.77%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BridgeBio Pharma (NASDAQ:BBIO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.66%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$155.35 M Get BBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling BridgeBio Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BBIO Insider Buying and Selling by Quarter Ad DTIEver heard of this 8-day bitcoin profit window? Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window.It’s coming up quick. BridgeBio Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/19/2024Brian C StephensonCFOSell4,156$22.41$93,135.96 11/19/2024Neil KumarCEOSell27,389$22.41$613,787.49 9/13/2024Genetic Disorder L.P. KkrMajor ShareholderSell5,800,000$25.75$149,350,000.00 8/19/2024Brian C StephensonCFOSell4,155$24.69$102,586.95 8/19/2024Neil KumarCEOSell27,389$24.69$676,234.41 6/3/2024Randal W ScottDirectorSell1,000$28.84$28,840.00 JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late.3/1/2024Randal W ScottDirectorSell2,500$34.00$85,000.00 1/16/2024Hannah ValantineDirectorSell2,915$37.97$110,682.55 12/26/2023Frank MccormickDirectorSell100,000$42.06$4,206,000.00 12/18/2023Randal W ScottDirectorSell2,000$40.00$80,000.00 (Data available from 1/1/2013 forward) BBIO Insider Trading Activity - Frequently Asked Questions Who is on BridgeBio Pharma's Insider Roster? The list of insiders at BridgeBio Pharma includes Brian C Stephenson, Douglas A Dachille, Frank Mccormick, Genetic Disorder L.P. Kkr, Global Investors Lp Viking, Hannah Valantine, Neil Kumar, Randal W Scott, and Ronald J Daniels. Learn more on insiders at BBIO. What percentage of BridgeBio Pharma stock is owned by insiders? 24.66% of BridgeBio Pharma stock is owned by insiders. Learn more on BBIO's insider holdings. Which BridgeBio Pharma insiders have been selling company stock? The following insiders have sold BBIO shares in the last 24 months: Brian C Stephenson ($4,096,222.54), Frank Mccormick ($4,206,000.00), Genetic Disorder L.P. Kkr ($149,350,000.00), Global Investors Lp Viking ($52,500,000.00), Hannah Valantine ($110,682.55), Neil Kumar ($9,467,071.70), and Randal W Scott ($193,840.00). How much insider selling is happening at BridgeBio Pharma? Insiders have sold a total of 8,404,502 BridgeBio Pharma shares in the last 24 months for a total of $219,923,816.79 sold. BridgeBio Pharma Key ExecutivesDr. Neil Kumar Ph.D. (Age 45)Co-Founder, President, CEO & Director Compensation: $1.53MDr. Charles J. Homcy M.D. (Age 76)Co-Founder, Chairman of Pharmaceuticals & Independent Lead Director Compensation: $563.2kDr. Frank P. McCormick Ph.D. (Age 74)Co-Founder, Chairman of Oncology & Director Compensation: $542.78kDr. Brian C. Stephenson C.F.A. (Age 43)Ph.D., CFO & Secretary Compensation: $1.15MDr. Richard H. Scheller Ph.D. (Age 71)Chairman of Research & Development Compensation: $509.62kDr. Uma Sinha Ph.D. (Age 66)Chief Scientific Officer Compensation: $1.31MGrace RauhVice President of CommunicationsMr. Eli M. Wallace Ph.D. (Age 57)Chief Scientific Officer of Oncology Dr. Thomas Trimarchi Ph.D.Chief Product OfficerDr. Eric Michael David J.D. (Age 52)M.D., Ph.D., Chief Executive Officer of Gene Therapy More Insider Trading Tools from MarketBeat Related Companies Perrigo Insider Selling Amicus Therapeutics Insider Selling Arrowhead Pharmaceuticals Insider Selling Schrödinger Insider Selling Allakos Insider Selling Viatris Insider Selling Moderna Insider Selling Summit Therapeutics Insider Selling Genmab A/S Insider Selling Vaxcyte Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:BBIO) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BridgeBio Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BridgeBio Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBIO Stock Alerts